Pulmonary embolism (PE) is a major cause of mortality in the United States, with 100,000 to 180,000 deaths attributed to PE annually, according to the US Surgeon General.
Pulmonary embolism (PE) is a major cause of mortality in the United States, with 100,000 to 180,000 deaths attributed to PE annually, according to the US Surgeon General.
Access strategy for chronic total occlusions (CTOs) is crucial in obtaining procedural success. Some access sites may have a higher complication rate or be more technically difficult to obtain; therefore, the pros and cons of the approach...
Access strategy for chronic total occlusions (CTOs) is crucial in obtaining procedural success. Some access sites may have a higher complication rate or be more technically difficult to obtain; therefore, the pros and cons of the approach...
Popliteal venous aneurysms are a rare entity that at times can be fatal in the setting of pulmonary emboli. We report a case of a large popliteal venous aneurysm in a patient with a history of pulmonary embolism.
Popliteal venous aneurysms are a rare entity that at times can be fatal in the setting of pulmonary emboli. We report a case of a large popliteal venous aneurysm in a patient with a history of pulmonary embolism.
Severe iliofemoral arteriopathies precludes transfemoral access in approximately one-third of patients, but subclavian access represents an alternative option for these patients.
Severe iliofemoral arteriopathies precludes transfemoral access in approximately one-third of patients, but subclavian access represents an alternative option for these patients.
An 11-year old girl presented with history of recurrent pneumonia since early childhood and symptoms suggestive of gastroesophageal reflux. She was sent for cardiac evaluation as a part of a workup for persistent respiratory symptoms.
An 11-year old girl presented with history of recurrent pneumonia since early childhood and symptoms suggestive of gastroesophageal reflux. She was sent for cardiac evaluation as a part of a workup for persistent respiratory symptoms.
Ureteroarterial fistula represents an infrequent but potentially fatal cause of hematuria. The authors present the clinical course of an ureteroiliac arterial fistula in a patient who was managed by iliac stenting for 2 years and had an...
Ureteroarterial fistula represents an infrequent but potentially fatal cause of hematuria. The authors present the clinical course of an ureteroiliac arterial fistula in a patient who was managed by iliac stenting for 2 years and had an...
The authors describe an important technique to consider in the face of chronic total occlusions in patients with severe PAD in whom limb salvage is desired and who would otherwise be considered too high a surgical risk.
The authors describe an important technique to consider in the face of chronic total occlusions in patients with severe PAD in whom limb salvage is desired and who would otherwise be considered too high a surgical risk.
Popliteal artery entrapment syndrome (PAES) is a rare condition that occurs primarily in young active patients. We present a case series that highlights the diagnosis of PAES and represents the variability of outcomes based on timing of...
Popliteal artery entrapment syndrome (PAES) is a rare condition that occurs primarily in young active patients. We present a case series that highlights the diagnosis of PAES and represents the variability of outcomes based on timing of...
Popliteal artery entrapment syndrome (PAES) is a rare condition that occurs primarily in young active patients. We present a case series that highlights the diagnosis of PAES and represents the variability of outcomes based on timing of...
Popliteal artery entrapment syndrome (PAES) is a rare condition that occurs primarily in young active patients. We present a case series that highlights the diagnosis of PAES and represents the variability of outcomes based on timing of...
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA
▪ Integration follows successful trial of EchoSolv-AS by Beth Israel researchers on a historical cohort of 31,000 patients
▪ Trial...
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA
▪ Integration follows successful trial of EchoSolv-AS by Beth Israel researchers on a historical cohort of 31,000 patients
▪ Trial...
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Embolic device designed for improved preparation, delivery, and deep vessel filling for treating tumors and other interventional oncology uses.
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced today that the first...
Embolic device designed for improved preparation, delivery, and deep vessel filling for treating tumors and other interventional oncology uses.
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced today that the first...
NEW IBERIA, LA – Cardiovascular Institute of the South (CIS) and Iberia Medical Center (IMC) are the first in Acadiana to use the new FDA-approved Esprit™ BTK (Below the Knee) Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind...
NEW IBERIA, LA – Cardiovascular Institute of the South (CIS) and Iberia Medical Center (IMC) are the first in Acadiana to use the new FDA-approved Esprit™ BTK (Below the Knee) Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
